GlaxoSmithKline Consumer Healthcare Pakistan Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was PKR 7,127.15 million compared to PKR 5,234.83 million a year ago. Net income was PKR 556.6 million compared to PKR 615.01 million a year ago.

Basic earnings per share from continuing operations was PKR 4.76 compared to PKR 5.25 a year ago.